| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.47 | 0.003 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.44 | 0.004 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.007 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |